InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-8.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Countouriotis Athena, Chief Executive Officer. Officer active across 3 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 11 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €189k. Activity tracked since 9 February 2022. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
7,490 shares0Common StockSEC:0001628280-26-040922:0
6,650 shares0Common StockSEC:0001048477-25-000066:0
4,720 shares0Common StockSEC:0001048477-24-000096:0
2,180 shares0Common StockSEC:0001048477-23-000068:0
110,959 shares@ US$76.0097.8% of flowCommon StockSEC:0001209191-22-046258:0
2,971 shares@ US$36.3050.0% of flowCommon StockSEC:0001209191-22-008979:0
2,971 shares@ US$36.301.1% of flowCommon StockSEC:0001209191-22-008979
7,500 sharesCommon StockSEC:0001179110-16-017498:0
3,257 sharesCommon StockSEC:0001179110-16-017498:1
15,050 sharesCommon StockSEC:0001179110-16-016968:0
5,655 sharesCommon StockSEC:0001179110-16-016968:1
11 of 11 declarations
About Countouriotis Athena
Athena Countouriotis is the President and CEO at Turning Point Therapeutics, Inc. She is responsible for the strategic direction and management of the company's operations. Athena plays a vital role in developing growth initiatives and enhancing customer experience. Her leadership and strategic vision are crucial for Turning Point's success.
